Disclosures Y. Brede and A. Lowy are employees of Novartis Pharma AG, Basel, Switzerland, and are therefore eligible for Novartis stock and stock options. M. Burnier has received research grants from, and has been a speaker for, Novartis Pharma AG and AARDEX Ltd.
Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril
Version of Record online: 6 JAN 2011
© 2011 Blackwell Publishing Ltd
International Journal of Clinical Practice
Volume 65, Issue 2, pages 127–133, February 2011
How to Cite
Burnier, M., Brede, Y. and Lowy, A. (2011), Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril. International Journal of Clinical Practice, 65: 127–133. doi: 10.1111/j.1742-1241.2010.02616.x
- Issue online: 16 JAN 2011
- Version of Record online: 6 JAN 2011
- Paper received October 2010, accepted December 2010
Vol. 65, Issue 7, 820, Version of Record online: 16 JUN 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.